{"id":"W2136541422","doi":"10.1016/s1470-2045(13)70380-2","title":"Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":799,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"Celgene","keywords":"Pomalidomide; Dexamethasone; Medicine; Lenalidomide; Refractory (planetary science); Internal medicine; Multiple myeloma; Clinical endpoint; Bortezomib; Population; Thalidomide; Progressive disease; Clinical trial; Phases of clinical research; Oncology; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002151439,0.002722625,0.003762455,0.0005222539,0.0005407553,0.001731629,0.001763945,0.002382675,0.009994194],"category_scores_gemma":[0.002124199,0.000897209,0.003731199,0.0007176638,0.002066078,0.001744676,0.000779404,0.005390675,0.001620145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001614057,"about_ca_system_score_gemma":0.001437796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002265129,"about_ca_topic_score_gemma":0.003978742,"domain_scores_codex":[0.9992623,0.000385938,0.00003920473,0.0001441617,0.0000481532,0.000120353],"domain_scores_gemma":[0.9989422,0.0003529156,0.0002095811,0.00008147049,0.00003659866,0.0003773166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9886956,0.002267034,0.0002116398,0.0003173516,0.0006636717,0.00002119473,0.00003902381,0.0002481049,0.0007869022,0.00009040855,0.0006345232,0.006024588],"study_design_scores_gemma":[0.9786839,0.01991208,0.0004613813,0.00001867459,0.0002260165,0.00001688505,0.00001441083,0.0001777979,0.00008989887,0.0001614097,0.0002281124,0.000009437439],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9800875,0.006784879,0.0007802942,0.002023343,0.001266805,0.003595009,0.002160327,0.0002382363,0.003063537],"genre_scores_gemma":[0.9847719,0.002936242,0.001725687,0.001931795,0.0006236575,0.002858542,0.001296234,0.00004526437,0.003810605],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009994194,"threshold_uncertainty_score":0.03343385,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08314179518883183,"score_gpt":0.3790846202528805,"score_spread":0.2959428250640487,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}